KPMG Abogados instructed on Advent’s sale of Alcala Farma

Advent International Corporation was advised by KPMG Abogados on the sale of Spanish pharmaceutical contract development and manufacturing organisation Alcala Farma to Groupe Synerlab.


Alcala Farma, which has annual sales of €25 million, manufactures pharmaceutical drugs that come in multiple dosage forms, including injectable, oral and topical products.

French headquartered Synerlab was advised by CMS on the deal, according to Mergermarket data.

Synerlab has annual sales of almost €110m and has more than 700 employees located in five production sites in France.

A Synerlab statement said the acquisition of Alcala Farma – which was financed by Synerlab shareholders 21 Partners and Ardian – is expected to increase the group’s revenue base by more than 20 per cent, with the proportion of sales outside France rising from 30 per cent to 45 per cent.

KPMG Abogados instructed on Advent’s sale of Alcala Farma

Ben Cook

Iberian Lawyer, is a monthly digital magazine, published by LC Publishing, available in Spanish and English. It represents the main source of information in the legal business sector in Spain and Portugal. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store.

In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors.

For further information, please visit the Group’s website

Iberian Lawyer
Registered office: C/ Manuel Silvela, 8 - Oficinas 1 Dcha 28010 Madrid España

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram